Exam 1: Management Algorithm for Interrupting Mother to Child Transmission of Hepatitis B Virus
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 18, 2019 Category: Gastroenterology Tags: Continuing Medical Education (CME) Activity Source Type: research

Lifetime Economic Burden of Crohn ’s Disease and Ulcerative Colitis by Age at Diagnosis
Understanding the burden of Crohn ’s disease (CD) and ulcerative colitis (UC) is important for measuring treatment value. We estimated lifetime healthcare costs incurred by patients with CD or UC by age at diagnosis. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 18, 2019 Category: Gastroenterology Authors: Gary R. Lichtenstein, Ahva Shahabi, Seth A. Seabury, Darius N. Lakdawalla, Oliver D íaz Espinosa, Sarah Green, Michelle Brauer, Robert N. Baldassano Source Type: research

Global Prevalence of Colorectal Neoplasia: a Systematic Review and Meta-analysis
We examined the prevalence of any type of adenomas, advanced adenomas (AAD), and CRC according to age, sex, ethnicity, geographical regions, and anatomic location (proximal vs distal). (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: Martin CS. Wong, Junjie Huang, Jason LW. Huang, Tiffany WY. Pang, Peter Choi, Jingxuan Wang, Jason I. Chiang, Johnny Yu Jiang Source Type: research

Methylated DNA in Pancreatic Juice Distinguishes Patients With Pancreatic Cancer From Controls
Precursors of pancreatic cancer arise in the ductal epithelium; markers exfoliated into pancreatic juice might be used to detect high-grade dysplasia (HGD) and cancer. Specific methylated DNA sequences in pancreatic tissue have been associated with adenocarcinoma. We analyzed these methylated DNA markers (MDMs) in pancreatic juice samples from patients with pancreatic ductal adenocarcinomas (PDACs) or intraductal papillary mucinous neoplasms (IPMNs) with HGD (cases), and assessed their ability to discriminate these patients from individuals without dysplasia or with IPMNs with low-grade dysplasia (IPMN-LGD) (controls). (So...
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: Shounak Majumder, Massimo Raimondo, William R. Taylor, Tracy C. Yab, Calise K. Berger, Brian A. Dukek, Xiaoming Cao, Patrick H. Foote, Chung Wah Wu, Mary E. Devens, Douglas W. Mahoney, Thomas C. Smyrk, Rahul Pannala, Suresh T. Chari, Santhi Swaroop Vege, Source Type: research

Durability of Spontaneous and Treatment-related Loss of Hepatitis B s Antigen
Clearance of hepatitis B surface antigen (HBsAg) from serum is the most desirable endpoint and a proposed definition of functional cure for hepatitis B virus (HBV) infection. However, little is known about the long-term durability of HBsAg loss, and there is controversy over whether the development of antibodies against HBsAg (anti-HBs) is required for maintenance. We aimed to assess the durability of spontaneous or treatment-related (interferon or nucleos(t)ide analogue [NA]) loss of HBsAg. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: Ahmad Samer Alawad, Sungyoung Auh, Daniel Suarez, Marc G. Ghany Source Type: research

Effects of Psychology and Extra-Gastrointestinal Symptoms on Healthcare Use by Subjects With and Without Irritable Bowel Syndrome
There is controversy about whether psychological factors (anxiety and depression) increase seeking of healthcare by patients with irritable bowel syndrome (IBS). We investigated whether psychological factors increase healthcare seeking by patients with IBS and the effects of extra-GI symptoms. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: David T. McNaughton, Anna Andreasson, Brj ánn Ljótsson, Alissa P. Beath, Julia M. Hush, Nicholas J. Talley, Gunnar Ljunggren, Peter T. Schmidt, Lars Agréus, Michael P. Jones Source Type: research

All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: Giulia Roda, Ana Lleo, Silvio Danese, Alessio Aghemo Source Type: research

Predictors of retention in care among a cohort of chronically HBV infected patients. What are we missing?
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 16, 2019 Category: Gastroenterology Authors: L. Magnasco, L. Di Nino, L.A. Nicolini Source Type: research

Clinical Factors Associated With Gastric Cancer in Individuals with Lynch Syndrome
Lynch syndrome is the most common inherited cause of gastrointestinal cancer and increases risk for a variety of malignancies, including gastric cancer. We aimed to identify clinical factors associated with gastric cancer in carriers of germline variants causing Lynch syndrome. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 15, 2019 Category: Gastroenterology Authors: Jaihwan Kim, Danielle Braun, Chinedu Ukaegbu, Tara G. Dhingra, Fay Kastrinos, Giovanni Parmigiani, Sapna Syngal, Matthew B. Yurgelun Source Type: research

Long-term Liver-related Outcomes of Patients with Chronic Liver Diseases in Australia
Chronic liver disease is a major health burden that produces significant liver-related morbidity and mortality. We aimed to evaluate liver-related outcomes of patients with different causes of chronic liver disease in Australia. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 15, 2019 Category: Gastroenterology Authors: Yi Huang, John Joseph, W Bastiaan de Boer, Wendy Cheng, Leon A. Adams, Gerry MacQuillan, George Garas, Spiro Raftopoulos, Gary P. Jeffrey Source Type: research

What Patients Need to Know About Living With IBD
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 15, 2019 Category: Gastroenterology Authors: Lucia V. Allen Source Type: research

Phenotypes of Gastroesophageal Reflux Disease: Where Rome, Lyon, and Montreal Meet
Gastroesophageal reflux disease (GERD) is now one of the most common diagnoses made in a gastroenterology practice. From a conventional pathophysiological perspective GERD is conceptualized as incompetence of the antireflux barrier at the esophagogastric junction; the more severe that incompetence, the worse the disease. However, it is increasingly clear that many presentations of GERD represent distinct phenotypes with unique predisposing cofactors and pathophysiology outside of this paradigm. Three major consensus initiatives have grappled with this dilemma (the Montreal Consensus, The Rome Foundation, and the Lyon Conse...
Source: Clinical Gastroenterology and Hepatology - July 15, 2019 Category: Gastroenterology Authors: David A. Katzka, John E. Pandolfino, Peter J. Kahrilas Source Type: research

Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries
Treatment of chronic hepatitis B virus (HBV) infection with entecavir suppresses virus replication and reduces disease progression, but could require life-long therapy. To investigate clinical outcome events and safety associated with long-term treatment with entecavir, we followed patients treated with entecavir or another standard of care HBV nucleos(t)ide analogue for up to 10 years. We assessed long-term outcomes and relationships with virologic response. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 12, 2019 Category: Gastroenterology Authors: Jin-Lin Hou, Wei Zhao, Changhyeong Lee, Hie-Won Hann, Cheng-Yuan Peng, Tawesak Tanwandee, Viacheslav Morozov, Hartwig Klinker, Jose D. Sollano, Adrian Streinu-Cercel, Hugo Cheinquer, Qing Xie, Yu-Ming Wang, Lai Wei, Ji-Dong Jia, Guozhong Gong, Kwang-Hyub Source Type: research

AGA Institute Clinical Practice Update: Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 12, 2019 Category: Gastroenterology Authors: Christopher L. Bowlus, Joseph K. Lim, Keith D. Lindor Source Type: research

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases
Exposure to hormone contraception has been associated with an increased risk of relapse of inflammatory bowel diseases (IBD). Little is known about the effects of cancer therapies, specifically hormone therapies, on the course of IBD. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 11, 2019 Category: Gastroenterology Authors: Jordan E. Axelrad, Ahmad Bazarbashi, James Zhou, Daniel Casta ñeda, Amandeep Gujral, Dylan Sperling, Jason Glass, Manasi Agrawal, Simon Hong, Garrett Lawlor, David Hudesman, Shannon Chang, Shailja Shah, Vijay Yajnik, Ashwin Ananthakrishnan, Hamed Khalili Source Type: research

Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 11, 2019 Category: Gastroenterology Authors: Christopher J. Black, Nicholas E. Burr, Alexander C. Ford Source Type: research

A Uncommon Cause of Gastric Varix and Ascites
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 11, 2019 Category: Gastroenterology Authors: Shu-Wei Liang, Ming-Wun Wong, Chien-Lin Chen Tags: Image of the Month Source Type: research

Are We Moving in the Right Direction by Altering Gastric Motility for Weight Loss?
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 11, 2019 Category: Gastroenterology Authors: Reem Z. Sharaiha, Vivek Kumbhari Source Type: research

Response
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 10, 2019 Category: Gastroenterology Authors: Dennis Yang, Peter V. Draganov Source Type: research

Ulcerative Colitis and Crohn ’s Disease Have the Same Burden and Goals for Treatment
It is unclear whether ulcerative colitis (UC) is a progressive disease like Crohn ’s disease (CD). Patients with UC are often undertreated, because of the possibility of curative colectomy and the perception that the disease burden is lower than that of CD. We discuss findings from studies that aimed to determine whether UC and CD have the same disease burden and should be trea ted in the same intensive way. We discuss the similarities between CD and UC, including effects on quality of life, long-term complications, strictures, increased risk of cancer, pseudopolyps, functional abnormalities, and anorectal dysfunctio...
Source: Clinical Gastroenterology and Hepatology - July 10, 2019 Category: Gastroenterology Authors: Catherine Le Berre, Ashwin N. Ananthakrishnan, Silvio Danese, Siddharth Singh, Laurent Peyrin-Biroulet Source Type: research

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients
Studies in mice have shown that the intestinal microbiota can contribute to obesity via the anorexigenic gut hormone glucagon-like peptide 1 (GLP1) and bile acids, which affect lipid metabolism. We performed a randomized, placebo-controlled pilot study of the effects of fecal microbiota transplantation (FMT) in obese, metabolically uncompromised patients. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 10, 2019 Category: Gastroenterology Authors: Jessica R. Allegretti, Zain Kassam, Benjamin H. Mullish, Austin Chiang, Madeline Carrellas, Jonathan Hurtado, Julian R. Marchesi, Julie A.K. McDonald, Alexandros Pechlivanis, Grace F. Barker, Jesus Miguens Blanco, Isabel Garcia-Perez, Wing Fei Wong, Ylain Source Type: research

Response to: Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients (CGH-D-19-01071)
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: John B. Kisiel, Douglas W. Mahoney, William R. Taylor, Paquale Klepp Source Type: research

An Unexpected Case of Right Iliac Fossa Pain: Amyand Hernia
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: Teo Qi Tian, Kam Juinn Huar, Tousif Kabir Source Type: research

Additional Intestinal Mucosal Biopsy Sampling for Research is Safe During Pediatric Endoscopic Procedures
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: Christopher J. Moran, Julia Noreck, Harland S. Winter, Emma X. Li, Jeffrey A. Biller, Esther J. Israel, Jess L. Kaplan Source Type: research

Do Alterations in Bone Mineral Density Go Beyond Borders In Adults With Celiac Disease?
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: Gloria Galli, Edith Lahner, Bruno Annibale Source Type: research

Respectful Payer Provider Collaboration Can Achieve the Best in Value-Based Care
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: Lili Brillstein, Joel V. Brill, Brian Currie Source Type: research

Medical Professional Liability in Gastroenterology: Understanding the Claims Landscape and Proposed Mechanisms for Reform
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - July 4, 2019 Category: Gastroenterology Authors: Megan A. Adams, John I. Allen Source Type: research

Hepatocellular Carcinoma Among Hispanics: An Understudied Public Health  Priority
We read the article by Kim et  al,1 “Disparate Trends in Mortality of Etiology-Specific Chronic Liver Disease Among Hispanic Sub-populations”, with great interest. Liver cancer, and hepatocellular carcinoma (HCC) in particular, has historically disproportionately impacted Hispanics in the United States. Although considerabl e and important differences have been documented by disaggregated Hispanic subgroups,2–4 this variation has largely been overlooked in liver cancer prevention and control efforts. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Authors: Karen E. Callahan, Paulo S. Pinheiro Tags: Letter to the Editor Source Type: research

Endoscopic Ultrasound
An endoscopic ultrasound (EUS) is a specialized procedure using endoscopy and ultrasound to view your upper or lower gastrointestinal system. EUS is performed by a gastroenterologist with advanced training. Endoscopy is when a scope (a thin, flexible tube with a camera and a light on the end) is used to look at the gastrointestinal tract, and ultrasound is the use of high-frequency sound waves to see detailed images of the bowel wall and nearby organs or structures. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Tags: AGA Patient Education Section Source Type: research

Issue Highlights
In the Study of Biologic and Immunomodulator Naive Patients in Crohn ’s Disease (SONIC) trial, patients with moderate-to-severe Crohn’s disease (CD) who were treated with infliximab in combination with azathioprine (AZA) and were naïve to both drugs achieved higher corticosteroid-free remission and endoscopic healing than either drug alone at Week 26. To determi ne if thiopurines impact the pharmacokinetics of infliximab or works synergistically with infliximab, Colombel and colleagues1 performed a post hoc analysis of study data from 206 CD patients (97 on infliximab monotherapy and 109 on combination the...
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Authors: Lin Chang Tags: Issue highlights Source Type: research

Exam 1: Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Tags: Continuing Medical Education (CME) Activity Source Type: research

Editorial Board
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Contents
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Elsewhere in The AGA Journals
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Information for Authors and Readers
Clinical Gastroenterology and Hepatology is the go-to resource on a broad spectrum of themes in clinical gastroenterology and hepatology. The official clinical practice journal of the AGA Institute brings you the best original research in the field with a unique combination of reviews, editorials, podcasts, video abstracts, and outcomes research —all supporting clinical practice. Articles on education, policy, and practice management highlight issues pertinent to clinicians. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Information for Authors
Clinical Gastroenterology and Hepatology (CGH) publishes clinical articles on all aspects of the digestive system, including the liver and pancreas. The types of articles Clinical Gastroenterology and Hepatology publishes include original papers,  review articles, and special category manuscripts. Manuscripts must be prepared in accordance with the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” developed by the International Committee of Medical Journal Editors (ICMJE) (http://www.icmje.org). (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Cover
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 28, 2019 Category: Gastroenterology Source Type: research

Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 27, 2019 Category: Gastroenterology Authors: Fredrik Åberg, Pauli Puukka, Veikko Salomaa, Satu Männistö, Annamari Lundqvist, Liisa Valsta, Markus Perola, Antti Jula, Martti Färkkilä Source Type: research

Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 27, 2019 Category: Gastroenterology Authors: Stephen B. Hanauer, Stefan Schreiber Source Type: research

Reply
We thank Drs Dai, Jiang, and Sun for their comments1 on our study.2 We confirmed that fecal calprotectin (fCal) is the best biomarker for predicting endoscopic disease activity in patients with Crohn ’s disease, but its sensitivity and specificity have been shown to be affected by numerous factors including the time between bowel movements and gastrointestinal inflammation from sources other than Crohn’s disease. These factors explain part of the inter- and intrapatient variability of fCal l evels that is not related to the disease activity and thus confound a correct interpretation of the measurement results. ...
Source: Clinical Gastroenterology and Hepatology - June 26, 2019 Category: Gastroenterology Authors: Erwin Dreesen, Ann Gils Tags: Letter to the Editor Source Type: research

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn ’s Disease
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 26, 2019 Category: Gastroenterology Authors: Erwin Dreesen, Ann Gils Source Type: research

Patients Eligible for Trials of Microbe-based Therapeutics do not Represent the Population With Recurrent Clostridioides difficile Infection
Although there are many industry-funded trials of microbe-based therapeutics for Clostridioides (formerly Clostridium) difficile infection (CDI), not all patients are eligible for these trials, due to their strict enrollment criteria. Furthermore, given the widespread availability of fecal microbiota transplantation (FMT) and overwhelming evidence to support its efficacy, patients might refuse enrollment in trials with a placebo group. We analyzed willingness and eligibility of patients with recurrent CDI to participate in randomized controlled trials of microbe-based therapeutic agents. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 26, 2019 Category: Gastroenterology Authors: Colleen R. Kelly, Monika Fischer, Ari Grinspan, Jessica R. Allegretti Source Type: research

Microscopic Colitis is Characterized by Intestinal Dysbiosis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 26, 2019 Category: Gastroenterology Authors: David M. Morgan, Yueming Cao, Kaia Miller, Jessica McGoldrick, Danielle Bellavance, Samantha M. Chin, Stefan Halvorsen, Benjamin Maxner, James M. Richter, Slim Sassi, Kristin E. Burke, Joseph C. Yarze, Jonas F. Ludvigsson, Kyle Staller, Daniel C. Chung, H Source Type: research

Reply
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Hye Won Lee, Beom Kyung Kim Source Type: research

Nine Taenia saginata inhabit the intestine in a patient
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Dong Ling, Li Qingcui, Li Hailong Tags: Image of the Month Source Type: research

Validation of the CAMD score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy
Researchers previously developed a scoring system to determine risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection, based on presence of cirrhosis and diabetes and patient age and male gender (called CAMD scoring system). We validated the CAMD scoring system and compared its performance with that of other risk assessment models in an independent cohort. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Seung Up Kim, Yeon Seok Seo, Han Ah Lee, Mi Na Kim, Eun Hwa Kim, Ha Yan Kim, Yu Rim Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seong Gyu Hwang, Kyu Sung Rim, Soon Ho Um, Won Young Tak, Young Oh Kweon, Beom Kyung Kim, Soo Source Type: research

Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis
In some individuals with undetectable serum levels of hepatitis B surface antigen (HBsAg), hepatitis B virus (HBV) DNA can still be detected in serum or hepatocytes and HBV replicates at low levels —this is called occult HBV infection (OBI). OBI has been associated with increased risk of hepatocellular carcinoma (HCC). We investigated the incidence of OBI in patients with HCC and other liver diseases. We also investigated whether, in patients with OBI and HCC, HBV DNA has integrated into the DNA of hepatocytes. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Danny Ka-Ho Wong, Serene Ching Yan Cheng, Loey Lung-Yi Mak, Elvis Wai-Pan To, Regina Cheuk-Lam Lo, Tan-To Cheung, Wai-Kay Seto, James Fung, Kwan Man, Ching-Lung Lai, Man-Fung Yuen Source Type: research

Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean —a Systematic Review
The incidence of inflammatory bowel diseases (IBD) is increasing in Latin America. We performed a systematic review to identify clinical and epidemiologic features of IBD in Latin America (including Mexico, Central America, and South America) and the Caribbean. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Paulo Gustavo Kotze, Fox E. Underwood, Aderson Omar Mour ão Cintra Damião, Jose Geraldo P. Ferraz, Rogerio Saad-Hossne, Martin Toro, Beatriz Iade, Francisco Bosques-Padilla, Fábio Vieira Teixeira, Fabian Juliao-Banos, Daniela Simian, Subrata Ghosh, Rem Source Type: research

Consumption of Fish and Long-chain n-3 Polyunsaturated Fatty Acids is Associated With Reduced Risk of Colorectal Cancer in a Large European Cohort
We examined the association between fish consumption, dietary and circulating levels of n-3 LC-PUFAs, and ratio of n-6:n-3 LC-PUFA with CRC using data from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Elom K. Aglago, Inge Huybrechts, Neil Murphy, Corinne Casagrande, Genevieve Nicolas, Tobias Pischon, Veronika Fedirko, Gianluca Severi, Marie-Christine Boutron-Ruault, Agn ès Fournier, Verena Katzke, Tilman Kühn, Anja Olsen, Anne Tjønneland, Christina Source Type: research

Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - June 25, 2019 Category: Gastroenterology Authors: Eduardo Vilar-Gomez, Naga Chalasani Source Type: research